Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Cancer Research
Molecular Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Rapid Impact Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Metabolism Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Spotlight on Genomic Analysis of Rare and Understudied Cancers
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Signal Transduction and Functional Imaging

E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms

Mohit Kumar Jolly, Kathryn E. Ware, Shengnan Xu, Shivee Gilja, Samantha Shetler, Yanjun Yang, Xueyang Wang, R. Garland Austin, Daniella Runyambo, Alexander J. Hish, Suzanne Bartholf DeWitt, Jason T. George, R. Timothy Kreulen, Mary-Keara Boss, Alexander L. Lazarides, David L. Kerr, Drew G. Gerber, Dharshan Sivaraj, Andrew J. Armstrong, Mark W. Dewhirst, William C. Eward, Herbert Levine and Jason A. Somarelli
Mohit Kumar Jolly
1Center for Theoretical Biological Physics, Rice University, Houston, Texas.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn E. Ware
2Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shengnan Xu
2Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shivee Gilja
2Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samantha Shetler
2Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanjun Yang
1Center for Theoretical Biological Physics, Rice University, Houston, Texas.
3Department of Applied Physics, Rice University, Houston, Texas.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xueyang Wang
4School of Medicine, Johns Hopkins University, Baltimore, Maryland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Garland Austin
2Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R. Garland Austin
Daniella Runyambo
2Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander J. Hish
2Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Suzanne Bartholf DeWitt
5Department of Pathology, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason T. George
1Center for Theoretical Biological Physics, Rice University, Houston, Texas.
6Department of Bioengineering, Rice University, Houston, Texas.
7Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Timothy Kreulen
8Department of Orthopedics, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary-Keara Boss
9Flint Animal Cancer Center, Colorado State University, Fort Collins, Colorado.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexander L. Lazarides
8Department of Orthopedics, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander L. Lazarides
David L. Kerr
8Department of Orthopedics, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Drew G. Gerber
2Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dharshan Sivaraj
2Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andrew J. Armstrong
10Solid Tumor Program, Duke University Medical Center, Durham, North Carolina.
11Duke Prostate Center, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mark W. Dewhirst
12Department of Radiation Oncology, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
William C. Eward
8Department of Orthopedics, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Herbert Levine
1Center for Theoretical Biological Physics, Rice University, Houston, Texas.
6Department of Bioengineering, Rice University, Houston, Texas.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jason A. Somarelli
2Department of Medicine, Duke University Medical Center, Durham, North Carolina.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: jason.somarelli@duke.edu
DOI: 10.1158/1541-7786.MCR-18-0763 Published June 2019
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    E-cadherin upregulation is prognostic for improved outcomes in sarcoma. A and B, Osteosarcomas with elevated E-cadherin have better metastasis-free survival (A) and overall survival (B) as compared to tumors with low/no E-cadherin expression. C and D, Soft-tissue sarcomas (STS) from The Cancer Genome Atlas with higher E-cadherin mRNA (C) and protein expression (D) have improved overall survival as compared to tumors with low or no E-cadherin.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Ectopic E-cadherin expression in sarcoma cells does not alter EMT. A, Ectopic expression of E-cadherin in 143B human osteosarcoma cells has no influence on mesenchymal markers (Snail, Slug, Twist, Zeb1, Vimentin). B, E-cadherin expression has no effect on migration of 143B cells. C, Images in B were collected every 2 hours and quantified using the IncuCyte Zoom system. D, E-cadherin expression does not change invasion in 143B cells. E, Using mRNA expression of CDH1 (E-cadherin), empirical probably density functions of EMT scores for CDH1-high (red) and CDH1-low (blue) TCGA sarcoma sample were constructed by interpolation of the EMT score histogram (E < 0.5, 0.5 ≤ E/M ≤ 1.5, M > 1.5). EMT score distribution showed no significant difference when separated for E-cadherinhigh versus E-cadherinlow expression from analysis of publicly available sarcoma datasets.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    E-cadherin inhibits anchorage-independent growth of sarcomas. A, Anchorage-independent growth of 143B cells expressing E-cadherin was significantly inhibited. B and C, E-cadherin expression leads to reduces spheroid size in 143B (B) and U2OS cells (C).

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    Ectopic expression of E-cadherin in sarcoma cells inhibits phospho-CREB levels. A, A phospho-kinase array revealed that E-cadherin led to downregulation of phospho-CREB. B and C, E-cadherin-mediated phospho-CREB inhibition was verified by ELISAs (B) and Western blotting (C). D, Abrams canine osteosarcoma cells exhibited reduced phospho-CREB in E-cadherin-overexpressing cells. E, qRT-PCR confirmed knockdown of CREB with two independent siRNAs. F, Western blotting to confirm knockdown of CREB in 143B cells. G, CREB knockdown led to a modest downregulation of 143B colony growth in soft agar.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    TBX2 knockdown phenocopies E-cadherin–mediated CREB inhibition. A and B, TBX2 mRNA is downregulated in E-cadherin–expressing 143B cells (A) and U2OS cells (B). C, CREB knockdown with two independent siRNAs had no effect on TBX2 mRNA. D–F, Conversely, TBX2 knockdown, verified in D led to a significant reduction in CREB mRNA (E) and protein level (F).

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    E-cad/TBX2 interplay mediates anchorage-independent growth. A, Intracellular regulatory circuit modulating anchorage-independent (A.I.) growth. B, Mathematical model predicts similar effects of Ecad-OE and TBX2-KD on anchorage-independent growth. C, TBX2 knockdown using two independent siRNAs inhibited anchorage-independent growth of 143B cells. D, TBX2 downregulation did not affect sphere formation in the presence of ectopic E-cadherin expression. E, TBX2 knockdown upregulates E-cadherin mRNA. F, Western blot analysis of U2OS cells upon TBX2 knockdown indicates E-cadherin protein is not upregulated by loss of TBX2. Prostate cancer (PC) cell line, LNCaP, was used as a positive control for E-cadherin expression. G, The E-cadherin promoter is differentially methylated in sarcomas as compared with carcinomas. H, Synovial sarcomas, which often display epithelioid histopathologic features, have the lowest levels of E-cadherin promoter methylation of all sarcoma subtypes. I, Among soft-tissue sarcoma histologic subtypes, E-cadherin mRNA expression is the highest in synovial sarcomas. Letters indicate statistically significant associations between groups. Undifferentiated pleomorphic sarcoma (UPS), liposarcoma (LPS), leiomyosarcoma (LMS), synovial sarcoma (SS), malignant peripheral nerve sheath tumors (MPNST), and myxofibrosarcoma (MFS).

  • Figure 7.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 7.

    E-cadherin inhibits spheroid formation by increased cell–cell adhesion. A, E-cadherin causes tighter clustering of cells during spheroid formation. B, A mechanical model illustrates the relationship between particle distance to adhesion. C, A mechanical model predicts E-cadherin drives down spheroid size through an increase in cell–cell adhesion. D and E, As predicted in the model, ectopic E-cadherin expression increases cell–cell adhesion in 143B (D) and U2OS (E) cells.

Additional Files

  • Figures
  • Supplementary Data

    • Figure S1 - S1. E-cadherin over-expression does not alter sarcoma cell growth in monolayer culture.
    • Figure S2 - S2. Ectopic E-cadherin expression in sarcoma cells does not alter EMT.
    • Figure S3 - S3. CREB knockdown indicates it is downstream of E-cadherin and TBX2.
    • Figure S4 - S4. E-cadherin induces E- to N-cadherin switching in sarcoma cells.
    • Figure S5 - S5. Revised E-cad/TBX2 signaling model.
    • Figure S6 - S6. A mechanical model relates cell-cell adhesion to spheroid size.
    • Supplementary Data - Supplementary Data
PreviousNext
Back to top
Molecular Cancer Research: 17 (6)
June 2019
Volume 17, Issue 6
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Editorial Board (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms
(Your Name) has forwarded a page to you from Molecular Cancer Research
(Your Name) thought you would be interested in this article in Molecular Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms
Mohit Kumar Jolly, Kathryn E. Ware, Shengnan Xu, Shivee Gilja, Samantha Shetler, Yanjun Yang, Xueyang Wang, R. Garland Austin, Daniella Runyambo, Alexander J. Hish, Suzanne Bartholf DeWitt, Jason T. George, R. Timothy Kreulen, Mary-Keara Boss, Alexander L. Lazarides, David L. Kerr, Drew G. Gerber, Dharshan Sivaraj, Andrew J. Armstrong, Mark W. Dewhirst, William C. Eward, Herbert Levine and Jason A. Somarelli
Mol Cancer Res June 1 2019 (17) (6) 1391-1402; DOI: 10.1158/1541-7786.MCR-18-0763

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical Mechanisms
Mohit Kumar Jolly, Kathryn E. Ware, Shengnan Xu, Shivee Gilja, Samantha Shetler, Yanjun Yang, Xueyang Wang, R. Garland Austin, Daniella Runyambo, Alexander J. Hish, Suzanne Bartholf DeWitt, Jason T. George, R. Timothy Kreulen, Mary-Keara Boss, Alexander L. Lazarides, David L. Kerr, Drew G. Gerber, Dharshan Sivaraj, Andrew J. Armstrong, Mark W. Dewhirst, William C. Eward, Herbert Levine and Jason A. Somarelli
Mol Cancer Res June 1 2019 (17) (6) 1391-1402; DOI: 10.1158/1541-7786.MCR-18-0763
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Authors' Contributions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • PTK6 Oncogenic Activity Is SH2 Domain-Dependent
  • The ECM Mediates FGF-Induced ER Activity
  • AXL Inhibition Induces DNA Damage and Replication Stress
Show more Signal Transduction and Functional Imaging
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Rapid Impact Archive
  • Meeting Abstracts

Information for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About MCR

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Molecular Cancer Research
eISSN: 1557-3125
ISSN: 1541-7786

Advertisement